Home/Filings/4/0001569222-20-000001
4//SEC Filing

Micheli Francesco 4

Accession 0001569222-20-000001

CIK 0001270073other

Filed

May 14, 8:00 PM ET

Accepted

May 15, 4:55 PM ET

Size

5.4 KB

Accession

0001569222-20-000001

Insider Transaction Report

Form 4
Period: 2020-05-13
Transactions
  • Sale

    Common stock, par value $0.001 per share

    2020-05-13$84.60/sh595,578$50,385,8995,500,000 total(indirect: See Footnote)
Footnotes (2)
  • [F1]These shares are held by Genextra S.p.A. Mr. Micheli is the Executive Director and Chairman of the board of Genextra S.p.A. and, in such capacity, Mr. Micheli exercises voting control over the shares of common stock owned by Genextra S.p.A and investment control over such shares as authorized by the board of Genextra S.p.A. Mr. Micheli disclaims beneficial ownership with respect to any such shares, except to the extent of his pecuniary interest therein, if any.
  • [F2]Genextra S.p.A. will apply the proceeds from the sale to reduce outstanding indebtedness under its margin loan secured by its shares of Intercept's common stock, and for general corporate purposes.

Issuer

INTERCEPT PHARMACEUTICALS, INC.

CIK 0001270073

Entity typeother

Related Parties

1
  • filerCIK 0001569222

Filing Metadata

Form type
4
Filed
May 14, 8:00 PM ET
Accepted
May 15, 4:55 PM ET
Size
5.4 KB